Yanqin Wang

Dr. Yanqin Wang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
JCJinhu Chen
Jinhu Chen
ZGZhenlong Guan
Zhenlong Guan
LWLiqin Wang
Liqin Wang
GSGuangyao Song
Guangyao Song
BMBoqing Ma
Boqing Ma
YWYanqin Wang
Yanqin Wang
Objective.Parkinson's disease (PD) is a severe neurological disease and its risk factors remain largely unknown. A meta-analysis was carried out to investigate the relationship of overweight and obesity with PD.Methods.We used PubMed, EMBASE, and the Chinese National Knowledge Infrastructure (CNKI) databases to identify studies of associations between overweight/obesity and PD. Overweight, obesity, and PD were used as keywords, and published works were retrieved until September 30, 2013. The extracted data were classified(BMI≥30,25≤BMI<30,  and BMI<25)according to BMI values and analyzed using RevMan5.2 and Stata11.0.Results.Four cohort studies and three case-control studies were used to evaluate the association between overweight/obesity and PD, including 2857 PD patients and 5, 683, 939 cases of non-PD controls. There was a statistically significant difference between25≤BMI<30  and BMI<25in the cohort study (RR=1.17, 95%CI, 1.03–1.32, P=0.03), but there was no difference betweenBMI≥30  and BMI<25orBMI≥30  and 25≤BMI<30, where the respectiveRRwas 1.16 and 0.84; the respective 95%CIwas 0.67–2.01 and 0.61–1.15, respectively, and thePvalues were 0.60 and 0.28, respectively. Case-control studies showed that there was no statistical difference between any two groups.Conclusion.Meta-analysis showed that overweight might be a potential risk factor of PD. Demonstration of a causal role of overweight/obesity in PD development could have important therapeutic implications.Erratum to “Sensitization to Cockroach Allergen: Immune Regulation and Genetic Determinants”

24 November 2021 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
BCBing Cao
Bing Cao
YZYanqiu Zhang
Yanqiu Zhang
JCJinhu Chen
Jinhu Chen
PWPengyue Wu
Pengyue Wu
YDYuxuan Dong
Yuxuan Dong
YWYanqin Wang
Yanqin Wang

18 January 2022 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
PWPengyue Wu
Pengyue Wu
YDYuxuan Dong
Yuxuan Dong
JCJinhu Chen
Jinhu Chen
TGTianyuan Guan
Tianyuan Guan
BCBing Cao
Bing Cao
YWYanqin Wang
Yanqin Wang

21 January 2019 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
XLXiaoting Liu
Xiaoting Liu
JCJinhu Chen
Jinhu Chen
TGTianyuan Guan
Tianyuan Guan
HYHui Yao
Hui Yao
WZWenpei Zhang
Wenpei Zhang
YWYanqin Wang
Yanqin Wang
Parkinson’s disease (PD) is the second most common neurodegenerative disease, and it is a multifactorial disease with no definite diagnostic index. The aim of this study is to construct a molecular network to find molecules that play important roles in the progression of PD with the goal of using them diagnostically and for early intervention. We downloaded two gene expression profiles (GSE54536 and GSE100054) from the Expression Omnibus (GEO) database to analyze possible markers. The Genes were analyzed with GEO2R. There were 1790 and 967 differentially expressed genes (DEGs) in GSE54536 and GSE100054 respectively. A total of 125 genes co-exist in the DEGs of the two data sets. KEGG pathway analysis showed that 125 DEGs were enriched in Aldosterone synthesis and secretion, Gap junctions, Platelet activation, Rap1 signaling pathway, and Estrogen signaling pathway. There were 20 hub genes among 125 DEGs analyzed by PPI that involved in Platelet activation, Inflammatory response, Innate immune response, B cell receptor signaling, Stimulatory C-type lectin receptor signaling, Lipopolysaccharide response, Leukocyte migration, and Regulation of cell proliferation. Additionally, 42 differences in miRNAs were found in GSE100054. We constructed a miRNA-mRNA regulatory network depicting interactions between the predicted genes and the 125 DEGs. 34 miRNA-mRNA pairs were obtained. We found GNAQ and TMTC2 were the most important mRNAs in the network analyzed by Cytoscape APP centiscape, and their degrees in centiscape2.2 were all 10. has-miR-142 was the most important miRNA (the highest degree is 4 in centiscape2.2), which forms miRNA-mRNA pairs with GNAQ, TMTC2, BEND2, and KYNU. This study provides data of potential biomarkers and therapeutic targets for PD diagnosis and treatment. Among them, hsa-miR-142 is a critical miRNA in the PD network, and may be involved in PD progression by regulating GNAQ, TMTC2, BEND2, and KYNU.

2 February 2018 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MLMin Liu
Min Liu
MFMarie Fitzgibbon
Marie Fitzgibbon
YWYanqin Wang
Yanqin Wang
JRJamie Reilly
Jamie Reilly
XQXiaohong Qian
Xiaohong Qian
Michelle RocheMichelle Roche
Michelle Roche
Excitation/inhibition imbalance has been proposed as a fundamental mechanism in the pathogenesis of neuropsychiatric and neurodevelopmental disorders, in which copy number variations of the Unc-51 like kinase 4 (ULK4) gene encoding a putative Serine/Threonine kinase have been reported in approximately 1/1000 of patients suffering pleiotropic clinical conditions of schizophrenia, depression, autistic spectrum disorder (ASD), developmental delay, language delay, intellectual disability, or behavioral disorder. The current study characterized behavior of heterozygous Ulk4 +/tm1a mice, demonstrating that Ulk4 +/tm1a mice displayed no schizophrenia-like behavior in acoustic startle reactivity and prepulse inhibition tests or depressive-like behavior in the Porsolt swim or tail suspension tests. However, Ulk4 +/tm1a mice exhibited an anxiety-like behavioral phenotype in several tests. Previously identified hypo-anxious (Atp1a2, Ptn, and Mdk) and hyper-anxious (Gria1, Syngap1, and Npy2r) genes were found to be dysregulated accordingly in Ulk4 mutants. Ulk4 was found to be expressed in GABAergic neurons and the Gad67+ interneurons were significantly reduced in the hippocampus and basolateral amygdala of Ulk4 +/tm1a mice. Transcriptome analyses revealed a marked reduction of GABAergic neuronal subtypes, including Pvalb, Sst, Cck, Npy, and Nos3, as well as significant upregulation of GABA receptors, including Gabra1, Gabra3, Gabra4, Gabra5, and Gabrb3. This is the first evidence that Ulk4 plays a major role in regulating GABAergic signaling and anxiety-like behavior, which may have implications for the development of novel anxiolytic treatments.

26 February 2024 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
YDYuxuan Dong
Yuxuan Dong
YQYueyan Qi
Yueyan Qi
JCJinhu Chen
Jinhu Chen
SHSiyuan Han
Siyuan Han
WSWenjing Su
Wenjing Su
YWYanqin Wang
Yanqin Wang
Intestinal dysbiosis plays a critical role in the pathogenesis of Parkinson’s disease (PD), and probiotics have emerged as potential modulators of central nervous system function through the microbiota-gut-brain axis. This study aimed to elucidate the anti-inflammatory effects and underlying mechanisms of the probiotic strain Bifidobacterium animalis subsp. lactis NJ241 (NJ241) in a mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The impact of NJ241 was comprehensively assessed in PD mice through behavioral tests, immunofluorescence, Western blotting, enzyme-linked immunosorbent assay (ELISA), 16S rRNA sequencing, and short-chain fatty acid (SCFA) detection. NJ241 exhibited notable efficacy in mitigating MPTP-induced weight loss, gastrointestinal dysfunction, and behavioral deficits in mice. Furthermore, it demonstrated protected against MPTP-induced dopaminergic neuron death and inhibited the activation of glial cells in the substantia nigra (SN). NJ241 demonstrated the ability to normalized dysbiosis in the intestinal microbiota and elevate SCFA levels in PD mice. Additionally, NJ241 reversed MPTP-induced reductions in colonic GLP-1 levels and the expression of GLP-1R and PGC-1α in the SN. Notably, GLP-1R antagonists partially reversed the inhibitory effects of NJ241 on the activation of glial cells in the SN. In summary, NJ241 exerts a neuroprotective effect against MPTP-induced neuroinflammation by enhancing intestinal GLP-1 levels and activating nigral PGC-1α signaling. These findings provide a rationale for the exploration and development of probiotic-based therapeutic strategies for PD.